Reply to the letter to the editor "Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients".
作者信息
Ushigusa Takeshi, Yoshida Atsushi, Kanomata Naoki
机构信息
Department of Pathology, St. Luke's International Hospital, 9 - 1, Akashi-cho, Chuo-ku, Tokyo, 104 - 8560, Japan.
Department of Breast Surgical Oncology, St. Luke's International Hospital, 9 - 1, Akashi-cho, Chuo-ku, Tokyo, 104 - 8560, Japan.
出版信息
Breast Cancer. 2025 Jul;32(4):881. doi: 10.1007/s12282-025-01703-9. Epub 2025 Apr 13.
PMID:40223028
Abstract
摘要
Zotero 插件